Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionGlenview Trust Co
Latest Disclosed Ownership7,821 shares
Latest Disclosed Value $ 2,751,818
Glenview Trust Co reports 0.46% decrease in ownership of AMGN / Amgen Inc.

On May 8, 2026 - Glenview Trust Co filed a 13F-HR form disclosing ownership of 7,821 shares of Amgen Inc. (MX:AMGN) valued at $2,751,818 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 7,857 shares of Amgen Inc.. This represents a change in shares of -0.46% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F AMGEN COM 031162100 7,821 -36 -0.46 2,752 7.00 0.0224
2026-02-09 2025-12-31 13F AMGEN COM 031162100 7,857 -554 -6.59 2,572 8.34 0.0397
2025-11-07 2025-09-30 13F AMGEN COM 031162100 8,411 -61 -0.72 2,374 0.34 0.0376
2025-08-14 2025-06-30 13F AMGEN COM 031162100 8,472 -56 -0.66 2,365 -10.96 0.0409
2025-05-20 2025-03-31 13F/A-1 AMGEN COM 031162100 8,528 -135 -1.56 2,657 17.68 0.0516
2025-05-15 2025-03-31 13F AMGEN COM 031162100 8,663 0 2,258 0.0220
2025-02-10 2024-12-31 13F AMGEN COM 031162100 8,663 -717 -7.64 2,258 -25.31 0.0423
2024-11-12 2024-09-30 13F AMGEN COM 031162100 9,380 -49 -0.52 3,022 2.58 0.0581
2024-08-14 2024-06-30 13F AMGEN COM 031162100 9,429 -168 -1.75 2,946 7.99 0.0593
2024-05-14 2024-03-31 13F AMGEN COM 031162100 9,597 105 1.11 2,729 -0.18 0.0586
2024-02-12 2023-12-31 13F AMGEN COM 031162100 9,492 323 3.52 2,734 10.92 0.0671
2023-11-13 2023-09-30 13F AMGEN COM 031162100 9,169 -78 -0.84 2,464 20.02 0.0680
2023-08-14 2023-06-30 13F AMGEN COM 031162100 9,247 146 1.60 2,053 -6.68 0.0560
2023-05-09 2023-03-31 13F AMGEN COM 031162100 9,101 110 1.22 2,200 -6.82 0.0659
2023-02-08 2022-12-31 13F AMGEN COM 031162100 8,991 -228 -2.47 2,361 13.62 0.0782
2022-11-04 2022-09-30 13F AMGEN COM 031162100 9,219 58 0.63 2,078 -6.77 0.0787
2022-08-10 2022-06-30 13F AMGEN COM 031162100 9,161 674 7.94 2,229 8.57 0.0819
2022-05-11 2022-03-31 13F AMGEN COM 031162100 8,487 999 13.34 2,053 21.91 0.0667
2022-02-10 2021-12-31 13F AMGEN COM 031162100 7,488 -275 -3.54 1,684 2.00 0.0557
2021-11-12 2021-09-30 13F AMGEN COM 031162100 7,763 -319 -3.95 1,651 -16.19 0.0638
2021-08-11 2021-06-30 13F AMGEN COM 031162100 8,082 60 0.75 1,970 -1.30 0.0761
2021-05-12 2021-03-31 13F AMGEN COM 031162100 8,022 1,047 15.01 1,996 24.44 0.0859
2021-02-02 2020-12-31 13F AMGEN COM 031162100 6,975 -50 -0.71 1,604 -10.14 0.0746
2020-11-12 2020-09-30 13F AMGEN COM 031162100 7,025 -9 -0.13 1,785 7.59 0.0925
2020-08-12 2020-06-30 13F AMGEN COM 031162100 7,034 -180 -2.50 1,659 13.47 0.0945
2020-04-28 2020-03-31 13F AMGEN COM 031162100 7,214 644 9.80 1,462 -7.70 0.1014
2020-02-06 2019-12-31 13F AMGEN COM 031162100 6,570 676 11.47 1,584 38.83 0.0886
2019-11-14 2019-09-30 13F AMGEN COM 031162100 5,894 560 10.50 1,141 16.07 0.0690
2019-08-08 2019-06-30 13F AMGEN COM 031162100 5,334 -1,483 -21.75 983 -24.09 0.0611
2019-05-14 2019-03-31 13F AMGEN COM 031162100 6,817 154 2.31 1,295 -0.15 0.0831
2019-02-14 2018-12-31 13F AMGEN COM 031162100 6,663 500 8.11 1,297 1.57 0.0958
2018-11-14 2018-09-30 13F AMGEN COM 031162100 6,163 6,163 1,277 0.0805
2018-08-10 2018-06-30 13F AMGEN COM 031162100 0 -6,255 -100.00 0 -100.00
2018-05-15 2018-03-31 13F/A-1 AMGEN COM 031162100 6,255 -21 -0.33 1,067 -2.29 0.0737
2018-05-14 2018-03-31 13F AMGEN COM 031162100 6,255 1,067
2018-02-06 2017-12-31 13F 1AMGEN COM 031162100 6,276 71 1.14 1,092 -5.62 0.0753
2017-11-07 2017-09-30 13F AMGEN COM 031162100 6,205 68 1.11 1,157 9.46 0.0847
2017-08-11 2017-06-30 13F AMGEN COM 031162100 6,137 25 0.41 1,057 5.38 0.0821
2017-05-10 2017-03-31 13F AMGEN COM 031162100 6,112 81 1.34 1,003 13.72 0.0793
2017-02-14 2016-12-31 13F/A-1 AMGEN COM 031162100 6,031 2,837 88.82 882 70.27 0.0731
2017-02-10 2016-12-31 13F 1AMGEN COM 031162100 6,031 882
2017-04-28 2015-12-31 13F AMGEN COM 031162100 3,194 725 29.36 518 31.81 0.0538
2017-05-01 2014-12-31 13F AMGEN COM 031162100 2,469 38 1.56 393 41.88 0.0419
2017-05-02 2013-12-31 13F AMGEN COM 031162100 2,431 2,431 277 0.0319
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.